Baycol Lawyers
Tuesday, March 09, 2010
About Us What Is Baycol? Baycol Recall Baycol Side Effects Rhabdomyolysis Baycol Litigation Other Statin Drugs Baycol FAQs Contact Us Home

The Baycol recall has lead to inquires as to when Bayer was first aware that fatal side effects were associated with Bacol , and whether Bayer failed to timely warn the public and health authorities of these side effects. The FDA is the organization that polices drug manufacturers. However, its authority is limited. It can order certain tests and reports be done to ensure product safety. It can order warnings accompany the product. I can order a recall of the product. However, it cannot order compensation to victims of a dangerous drug. That can only be done through the civil justice process.

A number of lawsuits have been filed against Bayer alleging, among other things: strict product liability, failure to warn, negligence and wrongful death.

One of the allegations is such lawsuits is that Bayer knew, by virtue of its own testing, that there was mounting clinical evidence and reports of physicians regarding serious side effects with Baycol. However, rather than tread softly and cautiously Bayer continued to market Baycol as safe and highly effective, will minimizing the associated risks.

Despite findings that Baycol posed serious health risks, Bayer continued to seek FDA approval for higher dosages of the drug. As a result recommended dosages increased from .2 mg to .8 mg., even though Bayer had knowledge of Rhabdomyolysis causing death and kidney failure in Baycol users as early as January, 2000. The associated dangers of the drug increased as the dosage increased. After receiving reports of an increased number of serious Rhabdomyolysis cases, Bayer adjusted the recommended dosage level in May of 2001.

On August 8, 2001 Bayer voluntarily recalled Baycol. This announcement came after numerous reports of sometimes fatal Rhabdomyolisis. At the time 31 deaths had been linked to the drug. In 12 of the 31 cases, the victims were taking Baycol in combination with gemfibrozil (Lopid), another lipid reducing medication. Since then, at least 100 deaths have been linked to the drug.

Many Baycol victims have now brought claims or filed suit in state and federal courts.

If you feel you have been harmed by use of Baycol, click here to have an attorney review your case for free, with no obligation. Or, call us toll free at 877.786.1LAW (1529).

VanDerGinst LawNursing Home AbuseHormone Replacement Therapy (HRT)Welding RodSlip & Fall AccidentsNational Legal Resources State Legal Resources

Public CitizenFood and Drug AdministrationAssociation of Trial Lawyers of AmericaCDER

Baycol Class Action Lawyer Website Disclaimer: The baycol recall, baycol class action lawsuit, settlement, mass tort drug litigation and/or other legal information offered herein by VanDerGinst Law is not formal legal advice nor the formation of an attorney client relationship. Our law firm handles law suits . Any results set forth here were dependent on the facts of that case and the results will differ from case to case. Please contact a baycol recall lawsuit attorney for advice on your rights.

The determination of the need for legal services and the choice of a lawyer are extremely important decisions and should not be based solely upon advertisements or self-proclaimed expertise. This disclosure is required by the Supreme Court of Iowa. Memberships and offices in legal fraternities and legal societies, technical and professional licenses, and memberships in scientific, technical and professional associations and societies of law or field of practice do not mean that a lawyer is a specialist or expert in a field of law nor do they mean that such a lawyer is necessarily any more expert or competent than any other lawyer. All potential clients are urged to make their own independent investigation and evaluation of any lawyer being considered. This notice is required by the rule of the Supreme Court of Iowa."
See Iowa Code of Professional Responsibility OR 2-101(A), OR 2-101(C), OR 2-105(A)(3)(c) (1997).